Hyderabad (Telangana) [India], February 13 (ANI/SRV): The healthcare sector in India is leaping forward with digital innovations at an accelerated pace. Government of India's initiatives like the National Digital Health Mission, integration of artificial intelligence, data governance, and 5G services fuelling a rapid paradigm shift in the healthcare industry which is already on the threshold of a new era of digital transformation. The Covid-19 pandemic primed the evolution of healthcare business models by channelizing novel digital concepts and strategies. Indian Immunologicals Limited (IIL) the Hyderabad-based subsidiary of the National Dairy Development Board (NDDB) has been at the forefront of business process innovation. Propelling the digital ecosystem, IIL, through its division Human Biologicals Institute, launched its first set of virtual medical representatives, a pioneering alternative to facilitate physician's interface in form of eMOz i.e. A virtual realm where e-rep
Indian Immunologicals Ltd (IIL) on Monday announced that it will invest Rs 700 crore to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad.
Hyderabad bags Rs 700 crore animal vaccine facility deccanchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deccanchronicle.com Daily Mail and Mail on Sunday newspapers.